Alexion Inks $125M Deal In Investors' Suit Over Sales Tactics

By Henrik Nilsson · September 13, 2023, 11:03 PM EDT

Alexion shareholders asked a Connecticut federal judge to approve a $125 million settlement to end claims that the drugmaker caused a double-digit plunge in stock price after its allegedly illegal sales...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Boston Retirement System v. Alexion Pharmaceuticals Inc et al

Case Number

3:16-cv-02127

Court

Connecticut

Nature of Suit

Securities/Commodities

Date Filed

December 29, 2016